Davis, Mellar P <br/><br/>
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.  [electronic resource] 

 -  Expert opinion on investigational drugs  Aug 2014 
 - 1123-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.2014.918603  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analgesics--pharmacology<br/>Animals<br/>Cannabinoid Receptor Agonists--adverse effects<br/>Cannabinoid Receptor Antagonists--adverse effects<br/>Cannabinoids--adverse effects<br/>Drug Design<br/>Endocannabinoids--metabolism<br/>Humans<br/>Ligands<br/>Pain--drug therapy<br/>Receptor, Cannabinoid, CB1--agonists<br/>Receptor, Cannabinoid, CB2--agonists